Additional Proxy Soliciting Materials (definitive) (defa14a)
August 21 2020 - 04:45PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
SCHEDULE 14A
Proxy
Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the
Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate
box:
| ☐ |
|
Preliminary Proxy Statement |
| |
|
| ☐ |
|
Confidential, for Use of the Commission Only
(as permitted by Rule 14a-6(e)(2)) |
| |
|
| ☐ |
|
Definitive Proxy Statement |
| |
|
| ☒ |
|
Definitive Additional Materials |
| |
|
| ☐ |
|
Soliciting Material Pursuant to
§ 240.14a-12 |
SENECA BIOPHARMA,
INC.
(Name
of Registrant as Specified In Its Charter)
(Name
of Person(s) Filing Proxy Statement, if other than the
Registrant)
Payment of Filing Fee (Check
the appropriate box):
| ☒ |
|
No fee required. |
| |
|
|
| ☐ |
|
Fee computed on table below per Exchange Act
Rules 14a-6(i)(1) and 0-11. |
| |
|
|
| |
|
(1) |
|
Title of each class of securities to which
transaction applies: |
| |
|
|
|
|
| |
|
|
|
|
| |
|
(2) |
|
Aggregate number of securities to which
transaction applies: |
| |
|
|
|
|
| |
|
|
|
|
| |
|
(3) |
|
Per
unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was
determined): |
| |
|
|
|
|
| |
|
|
|
|
| |
|
(4) |
|
Proposed maximum aggregate value of
transaction: |
| |
|
|
|
|
| |
|
|
|
|
| |
|
(5) |
|
Total
fee paid: |
| |
|
|
|
|
| |
|
|
|
|
| ☐ |
|
Fee paid previously with preliminary
materials. |
| |
|
|
| ☐ |
|
Check box if any part of the fee is offset as
provided by Exchange Act Rule 0-11(a)(2) and identify the filing
for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or
Schedule and the date of its filing. |
| |
|
|
|
|
|
(1) |
|
Amount Previously
Paid: |
| |
|
|
|
|
| |
|
|
|
|
| |
|
(2) |
|
Form,
Schedule or Registration Statement No.: |
| |
|
|
|
|
| |
|
|
|
|
| |
|
(3) |
|
Filing Party: |
| |
|
|
|
|
| |
|
|
|
|
| |
|
(4) |
|
Date
Filed: |
| |
|
|
|
|
Seneca Biopharma (NASDAQ:SNCA)
Historical Stock Chart
From Dec 2020 to Jan 2021
Seneca Biopharma (NASDAQ:SNCA)
Historical Stock Chart
From Jan 2020 to Jan 2021
